XENETIC BIOSCIENCES, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- XENETIC BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2019-06-30 was $0.00.
- XENETIC BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2019-03-31 was $17.43K, a 0.00% change year-over-year.
- XENETIC BIOSCIENCES, INC. stock issued during period, value, issued for services for the quarter ending 2018-03-31 was $17.43K.
- XENETIC BIOSCIENCES, INC. stock issued during period, value, issued for services for fiscal 2018 was $69.71K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $17.43K 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $69.71K 10-K · filed 2020-03-26 | |
| 2018-03-31 | $17.43K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |